Very good outside the box strategy for CYDY. CYDY
Post# of 153903
(Total Views: 643)
Posted On: 02/01/2022 4:50:35 PM
Re: Cassandra X #117086
Very good outside the box strategy for CYDY. CYDY is def veey unique company in unique situation. I think all High executives that have been keeping an eye or putting up road blocks for cydy from big pharma know that the day that any of these BTD EUA or straight out approval comes is a day of reckoning.
Some people think we are not in a buyout position right now. I say we are in perfect buyout situation now whether you are against it or not. Big pharma is often careful and patient on buyout ms of other drugs based on small limited pipeline and they want guarantee Sales revenue. CYDY after first major hurdle will prob take the biggest quickest leap from small time company to big time company that has ever happened to any company. A partnership is a good way for a big pharma to get their foot in the door and be first to act on a buyout. So we could see that as an approach but i think big pharma has woken up to the fact that CYDY is much more than a company with a HIV drug that is on its way to first revenue very soon and the landscape will change drastically for big pharma with huge almost deal breaking valuation if they sit around hoping and praying for Amarex to sabotage trial data because Sidley and eyes will be all over the next CRO. I just know that if i were CEO that understands the billions that are forecasted in near future for all the indications that one SAFE drug Leronlimab can potentially corner 10’s Billions in each of multiple markets yearly revenue. If they paid full price for 1-2 indications than all the others would be a huge huge bonus any buyer that puts up their best offer.
Some people think we are not in a buyout position right now. I say we are in perfect buyout situation now whether you are against it or not. Big pharma is often careful and patient on buyout ms of other drugs based on small limited pipeline and they want guarantee Sales revenue. CYDY after first major hurdle will prob take the biggest quickest leap from small time company to big time company that has ever happened to any company. A partnership is a good way for a big pharma to get their foot in the door and be first to act on a buyout. So we could see that as an approach but i think big pharma has woken up to the fact that CYDY is much more than a company with a HIV drug that is on its way to first revenue very soon and the landscape will change drastically for big pharma with huge almost deal breaking valuation if they sit around hoping and praying for Amarex to sabotage trial data because Sidley and eyes will be all over the next CRO. I just know that if i were CEO that understands the billions that are forecasted in near future for all the indications that one SAFE drug Leronlimab can potentially corner 10’s Billions in each of multiple markets yearly revenue. If they paid full price for 1-2 indications than all the others would be a huge huge bonus any buyer that puts up their best offer.
(6)
(0)